INTERNATIONAL PATENT: TRIOAR, INC., 주식회사 트리오어 FILES APPLICATION FOR "ANTI-CLAUDIN 18.2 ANTIBODY, ANTI-CLAUDIN 18.2 ANTIBODY-DRUG CONJUGATE AND USE THEREOF"

GENEVA, Dec. 30 -- TRIOAR, INC. (403ho, 361-17 Gapcheon-ro,Yuseong-gu,Daejeon 34037), 주식회사 트리오어 (대전광역시유성구갑천로 361-17, 403호) filed a patent application (PCT/KR2025/008602) for "ANTI-CLAUDIN 18.2 ANTIBODY, ANTI-CLAUDIN 18.2 ANTIBODY-DRUG CONJUGATE, AND USE THEREOF" on Jun 20, 2025. With publication no. WO/2025/264040, the details related to the patent application was published on Dec 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LEE, Hyun Mi (403ho, 3...